Vasiliki Zochiou – VJRegenMed https://mirror.vjregenmed.com The Video Journal of Regenerative Medicine Fri, 28 Jan 2022 09:23:19 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://d2xz56kaqxj8if.cloudfront.net/wp-content/uploads/2023/09/12102509/VJR-Favicon.png Vasiliki Zochiou – VJRegenMed https://mirror.vjregenmed.com 32 32 Analysing trends in the CAR-TCR landscape https://mirror.vjregenmed.com/video/fiqpebshqbs-analysing-trends-in-the-car-tcr-landscape/ Wed, 10 Mar 2021 19:30:18 +0000 http://13.40.107.223/video/fiqpebshqbs-analysing-trends-in-the-car-tcr-landscape/ Vasiliki Zochiou, PharmD, Beacon Targeted Therapies, London, UK, provides an overview of her presentation at the CAR-TCR Summit Europe 2021 focused on the evolution of the CAR-T and T-cell receptor (TCR) research landscape in recent years and how it has been impacted by the COVID-19 pandemic. Data suggests that in the last year, there has been a significant shift in the field toward allogeneic approaches and there has been rise in the number of allogeneic cell therapies that have entered preclinical pipelines and the clinic. Another growing trend in the field is the development of next-generation CAR therapies and research into construct design, manufacturing and armored CAR T-cells. This interview took place during the CAR-TCR Summit Europe 2021.

]]>